Incyte: Q3 Earnings Snapshot
Published . Updated .
Covered by 2 outlets: Yahoo Finance, WWLTV.com.
Who covered it: Center 1 · Not rated 1. How we rate outlets
This report does not map to a usual set of affected companies.
Directly affected
- INCY Incyte
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR-1.5% 30d
Industrial Select Sector SPDR holds the industrials sector that Incyte belongs to, so it often moves with news about it.
- IQV IQVIA Holdings+0.7% 12d
IQVIA Holdings is a peer of Incyte in commercial physical and biological research; rivals often move on the same news.
- MEDP Medpace Holdings+9.5% 12d
Medpace Holdings is a peer of Incyte in commercial physical and biological research; rivals often move on the same news.
- CRL Charles River Laboratories International+10.4% 13d
Charles River Laboratories International is a peer of Incyte in commercial physical and biological research; rivals often move on the same news.
- ICLR ICON Public-2.7% 16d
ICON Public is a peer of Incyte in commercial physical and biological research; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| INCY | +0.05% | -3.07% | base | -0.08% | +3.04% | after close | after close |
| XLINo price data for this ticker | — | — | — | — | — | — | — |
| IQVNo price data for this ticker | — | — | — | — | — | — | — |
| MEDPNo price data for this ticker | — | — | — | — | — | — | — |
| CRLNo price data for this ticker | — | — | — | — | — | — | — |
| ICLRNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Incyte: Q3 Earnings Snapshot Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| INCY | that day | -0.08% | final price |
| INCY | the next day | +3.04% | final price |
| INCY | three days earlier | -3.07% | final price |
| INCY | five days earlier | +0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 45 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 51 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 56 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Icon (ICLR) (jointly held), worth $15,001 - $50,000 on 14 Aug 2026. That is 76 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Incyte: Q3 Earnings Snapshot” looks
25 out of 100
“Incyte: Q3 Earnings Snapshot” scores 25 out of 100. The score uses 2 sources.